GLP-1 receptor agonists risk becoming another story of global health inequity-what can we learn from the response to HIV/AIDS? Ratevosian J, Sturchio JL. BMJ 2025;390:r1940.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ratevosian J, Sturchio JL. GLP-1 receptor agonists risk becoming another story of global health inequity-what can we learn from the response to HIV/AIDS? BMJ 2025;390:r1940.
PMID: 40957640